Classification of Research Peptides by Mechanism Class and Receptor Profile

Classifying research peptides by category name alone ("growth hormone peptides," "anti-inflammatory peptides") provides inadequate precision for protocol design or mechanistic interpretation. A receptor-based and pathway-based taxonomy is more useful: it allows researchers to predict pharmacological overlap, anticipate off-target risks, and select appropriate cellular or in vivo model systems for a given research question.

GPCR Agonists and Partial Agonists

The largest mechanistic class in research peptide portfolios are GPCR agonists. This includes: GLP-1 receptor agonists (exendin-4, semaglutide analogues, tirzepatide dual GLP-1R/GIPR agonist, retatrutide triple GLP-1R/GIPR/GCGR agonist) acting via G_s/cAMP in pancreatic β-cells, hypothalamus, and adipocytes; melanocortin receptor agonists (PT-141/bremelanotide at MC3R and MC4R, α-MSH fragments at MC1R for melanogenesis); GHS-R1a agonists (ipamorelin, sermorelin, CJC-1295) driving GH secretion from somatotrophs via G_q/IP3/Ca²⁺ and partially via G_s; and VPAC/PAC1 agonists involved in neuroprotection and circadian modulation. Critical for research design: receptor subtype selectivity must be verified — MC1R vs MC4R activation has opposing metabolic vs. sexual arousal endpoints, and GHS-R1a agonists differ significantly from GHRH-R agonists in kinetic profiles and feedback suppression.

Integrin and Extracellular Matrix-Modulating Peptides

Peptides interacting with integrin receptors (α_Vβ3, α5β1) and extracellular matrix components form a second major class relevant to wound healing, angiogenesis, and tumor biology research. TB-500 (Thymosin β4 fragment Ac-LKKTETQ) binds G-actin monomers (K_D ~0.5 μM) and indirectly modulates ILK (integrin-linked kinase)/PINCH/parvin complex assembly, promoting FAK phosphorylation and focal adhesion turnover. BPC-157 at 10 μg/kg i.p. in rodent models activates FAK/paxillin/src signaling and upregulates VEGFR2, driving endothelial tube formation in Matrigel assays with EC50 in the 1–10 ng/mL range in HUVEC cultures.

Mitochondria-Targeting Peptides

SS-31 (Elamipretide, D-Arg-Dmt-Lys-Phe-NH₂) represents a class of aromatic-cationic peptides that selectively partition to the inner mitochondrial membrane, binding cardiolipin and stabilizing Complex I–IV electron transport chain activity. In isolated cardiomyocyte ischemia-reperfusion models, SS-31 at 10–100 nM reduces mitochondrial ROS production by 60–80% (measured by MitoSOX fluorescence) and restores ΔΨm within 30 minutes of treatment initiation. This class is mechanistically distinct from GPCR peptides and requires mitochondrial membrane potential assays (JC-1, TMRE) and ATP production readouts rather than receptor binding measurements.

Growth Factor-Mimetic and Repair Peptides

GHK-Cu (Gly-His-Lys-Cu²⁺) activates Wnt/β-catenin signaling in fibroblast cultures (NIH/3T3, human dermal fibroblasts) by upregulating LRP5/6 co-receptor expression, and stimulates Nrf2 nuclear translocation, inducing antioxidant response element (ARE)-driven genes including SOD2, CAT, and GPx1. In ex vivo skin explant models, GHK-Cu at 1–10 μM increases collagen type I synthesis by 40–60% vs. vehicle controls. DSIP (Delta Sleep-Inducing Peptide) and related neuropeptides modulate GABAergic tone and ACTH secretion, requiring brain slice electrophysiology or radioligand displacement assays for characterization.

Alpha Nordisk presents this content for research documentation purposes. All products referenced are for research and laboratory use only. Not for unsupervised human consumption.